107 related articles for article (PubMed ID: 18535615)
1. Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model.
Solly F; Fish R; Simard B; Bolle N; Kruithof E; Polack B; Pernod G
Cancer Gene Ther; 2008 Oct; 15(10):685-92. PubMed ID: 18535615
[TBL] [Abstract][Full Text] [Related]
2. Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma.
Simard B; Bouamrani A; Jourdes P; Pernod G; Dimitriadou V; Berger F
Microvasc Res; 2011 Jul; 82(1):6-17. PubMed ID: 21406197
[TBL] [Abstract][Full Text] [Related]
3. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T; Cao Y; Folkman J; Fine HA
Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
[TBL] [Abstract][Full Text] [Related]
4. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effect of lentivirus-mediated gene transfer of alphastatin on human glioma.
Guo SW; Che HM; Li WZ
Cancer Sci; 2011 May; 102(5):1038-44. PubMed ID: 21255189
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model.
de Groot-Besseling RR; Ruers TJ; van Kraats AA; Poelen GJ; Ruiter DJ; de Waal RM; Westphal JR
Int J Cancer; 2004 Nov; 112(2):329-34. PubMed ID: 15352048
[TBL] [Abstract][Full Text] [Related]
8. Development of lentiviral vectors for antiangiogenic gene delivery.
Shichinohe T; Bochner BH; Mizutani K; Nishida M; Hegerich-Gilliam S; Naldini L; Kasahara N
Cancer Gene Ther; 2001 Nov; 8(11):879-89. PubMed ID: 11773978
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibitory effect of triple anti-tumor gene transfer using Semliki Forest virus vector in glioblastoma cells.
Lee JS; Lee JH; Poo H; Kim MS; Lee SH; Sung MH; Kim CJ
Int J Oncol; 2006 Mar; 28(3):649-54. PubMed ID: 16465369
[TBL] [Abstract][Full Text] [Related]
10. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.
Liang B; He ML; Chan CY; Chen YC; Li XP; Li Y; Zheng D; Lin MC; Kung HF; Shuai XT; Peng Y
Biomaterials; 2009 Aug; 30(23-24):4014-20. PubMed ID: 19427690
[TBL] [Abstract][Full Text] [Related]
11. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
14. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.
Yazawa H; Murakami T; Li HM; Back T; Kurosaka K; Suzuki Y; Shorts L; Akiyama Y; Maruyama K; Parsoneault E; Wiltrout RH; Watanabe M
Cancer Gene Ther; 2006 Nov; 13(11):993-1001. PubMed ID: 16763608
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model.
Griscelli F; Li H; Cheong C; Opolon P; Bennaceur-Griscelli A; Vassal G; Soria J; Soria C; Lu H; Perricaudet M; Yeh P
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6698-703. PubMed ID: 10823901
[TBL] [Abstract][Full Text] [Related]
16. Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model.
Doblas S; Saunders D; Kshirsagar P; Pye Q; Oblander J; Gordon B; Kosanke S; Floyd RA; Towner RA
Free Radic Biol Med; 2008 Jan; 44(1):63-72. PubMed ID: 18045548
[TBL] [Abstract][Full Text] [Related]
17. The recombinant kringle domain of urokinase plasminogen activator inhibits in vivo malignant glioma growth.
Kim CK; Hong SH; Joe YA; Shim BS; Lee SK; Hong YK
Cancer Sci; 2007 Feb; 98(2):253-8. PubMed ID: 17233842
[TBL] [Abstract][Full Text] [Related]
18. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
[TBL] [Abstract][Full Text] [Related]
19. Retinoids induced t-PA synthesis by C6 glioma cells--role in tumoral haemorrhagic necrosis.
Pernod G; Amalfitano G; Le Magueresse B; Berger F; Polack B; Kolodié L
Thromb Haemost; 1996 Feb; 75(2):332-8. PubMed ID: 8815586
[TBL] [Abstract][Full Text] [Related]
20. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy.
Wang CY; Li F; Yang Y; Guo HY; Wu CX; Wang S
Cancer Res; 2006 Jun; 66(11):5798-806. PubMed ID: 16740719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
